Simvastatin: Difference between revisions
David Canner (talk | contribs) No edit summary |
David Canner (talk | contribs) No edit summary |
||
| Line 2: | Line 2: | ||
===Better Known as: Zocor=== | ===Better Known as: Zocor=== | ||
* Marketed By: Merck & Co. Inc.<br /> | * Marketed By: Merck & Co. Inc.<br /> | ||
* Major Indication: Hyperlipidemia & High Cholesterol (Hypercholesterolemia)<br /> | * Major Indication: Hyperlipidemia & High Cholesterol ([[Metabolic Disorders|Hypercholesterolemia]])<br /> | ||
* Drug Class: [[HMGR]] Inhibitor or Statin | * Drug Class: [[HMGR]] Inhibitor or Statin | ||
* Date of FDA Approval (Patent Expiration): 1997 (2006)<br /> | * Date of FDA Approval (Patent Expiration): 1997 (2006)<br /> | ||